Tizanidine
Generic Name: tizanidine
Brand Names:
Tizanidine
11 DESCRIPTION Tizanidine Tablets contains tizanidine hydrochloride as the active ingredient, which is a central alpha 2 -adrenergic agonist. Its chemical name is 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3- benzothiadiazole monohydrochloride. It has a molecular formula of C 9 H 8 ClN 5 S-HCl and a molecular weight of 290.2. Its structural formula is: Tizanidine hydrochloride is a white to off-white, fine crystalline powder, which is odorless or with a faint characteristic odor.
Overview
11 DESCRIPTION Tizanidine Tablets contains tizanidine hydrochloride as the active ingredient, which is a central alpha 2 -adrenergic agonist. Its chemical name is 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3- benzothiadiazole monohydrochloride. It has a molecular formula of C 9 H 8 ClN 5 S-HCl and a molecular weight of 290.2. Its structural formula is: Tizanidine hydrochloride is a white to off-white, fine crystalline powder, which is odorless or with a faint characteristic odor.
Uses
1 INDICATIONS AND USAGE Tizanidine is a central alpha-2-adrenergic agonist indicated for the treatment of spasticity. ( 1 ) Tizanidine is indicated for the treatment of spasticity in adults.
Dosage
2 DOSAGE AND ADMINISTRATION Monitoring of aminotransferase levels is recommended at baseline and 1 month after maximum dose is achieved. ( 2.1 ) Recommended starting dose: 2 mg by mouth every 6 to 8 hours, as needed, up to a maximum of 3 doses in 24 hours ( 2.2 ) Dosage can be increased by 2 mg to 4 mg per dose every 1 to 4 days; maximum total daily dosage is 36 mg ( 2.2 ) Tizanidine pharmacokinetics differs between tablets and capsules, and when taken with or without food. These differences could result in a change in tolerability and control of symptoms. Consistent administration with respect to food is recommended. If substitution between dosage forms is necessary, take into consideration these pharmacokinetic differences.
Side Effects
6 ADVERSE REACTIONS The most common adverse reactions (greater than 10% of patients taking tizanidine and greater than in patients taking placebo) were dry mouth, somnolence, asthenia, and dizziness ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Unichem Pharmaceuticals (USA) Inc. at 1-866-562-4616 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Interactions
7 DRUG INTERACTIONS 7.1 Strong CYP1A2 Inhibitors Concomitant use of Tizanidine with strong cytochrome P450 1A2 (CYP1A2) inhibitors (e.g., fluvoxamine, ciprofloxacin) is contraindicated. Changes in pharmacokinetics of tizanidine when administered with a strong CYP1A2 inhibitor resulted in significantly decreased blood pressure, increased drowsiness, and increased psychomotor impairment [see Contraindications ( 4 ) and Clinical Pharmacology ( 12.3 )] . 7.3 Moderate or Weak CYP1A2 Inhibitors Concomitant use of Tizanidine with moderate or weak CYP1A2 inhibitors (e.g., zileuton, antiarrhythmics [amiodarone, mexiletine, propafenone, and verapamil], cimetidine, famotidine, oral contraceptives, acyclovir, and ticlopidine) should be avoided.
Warnings
5 WARNINGS AND PRECAUTIONS Hypotension: monitor for signs and symptoms of hypotension, in particular in patients receiving concurrent antihypertensives; tizanidine should not be used with other α 2 -adrenergic agonists ( 5.1 , 7.7 ) Risk of liver injury: monitor ALTs; discontinue tizanidine if liver injury occurs ( 5.2 ) Sedation: tizanidine may interfere with everyday activities; sedative effects of tizanidine, alcohol, and other central nervous system (CNS) depressants are additive ( 5.3 , 7.4 ) Hallucinations: consider discontinuation of tizanidine ( 5.4 ) 5.1 Hypotension Tizanidine is an α2-adrenergic agonist that can produce hypotension [see Adverse Reactions ( 6.1 ) and Drug Interactions ( 7.5 )] . 4 CONTRAINDICATIONS Concomitant use with strong CYP1A2 inhibitors ( 4 , 7.1 ) Patients with a history of hypersensitivity to tizanidine or the ingredients in Tizanidine ( 4 , 5.5 ) Tizanidine is contraindicated in patients: taking strong CYP1A2 inhibitors [see Drug Interactions ( 7.1 )]. with a history of hypersensitivity to tizanidine or the ingredients in Tizanidine.
Pregnancy
8.1 Pregnancy Risk Summary There are no adequate data on the developmental risk associated with use of tizanidine in pregnant women. In animal studies, administration of tizanidine during pregnancy resulted in developmental toxicity (embryofetal and postnatal offspring mortality and growth deficits) at doses less than those used clinically, which were not associated with maternal toxicity (see Animal Data ). In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% - 4% and 15% - 20%, respectively.
Storage
16 HOW SUPPLIED/STORAGE AND HANDLING Product: 50090-5767 NDC: 50090-5767-0 120 TABLET in a BOTTLE NDC: 50090-5767-2 60 TABLET in a BOTTLE NDC: 50090-5767-3 15 TABLET in a BOTTLE NDC: 50090-5767-4 30 TABLET in a BOTTLE NDC: 50090-5767-6 90 TABLET in a BOTTLE NDC: 50090-5767-7 14 TABLET in a BOTTLE
Frequently Asked Questions
What is Tizanidine used for?▼
1 INDICATIONS AND USAGE Tizanidine is a central alpha-2-adrenergic agonist indicated for the treatment of spasticity. ( 1 ) Tizanidine is indicated for the treatment of spasticity in adults.
What are the side effects of Tizanidine?▼
6 ADVERSE REACTIONS The most common adverse reactions (greater than 10% of patients taking tizanidine and greater than in patients taking placebo) were dry mouth, somnolence, asthenia, and dizziness ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Unichem Pharmaceuticals (USA) Inc. at 1-866-562-4616 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Can I take Tizanidine during pregnancy?▼
8.1 Pregnancy Risk Summary There are no adequate data on the developmental risk associated with use of tizanidine in pregnant women. In animal studies, administration of tizanidine during pregnancy resulted in developmental toxicity (embryofetal and postnatal offspring mortality and growth deficits) at doses less than those used clinically, which were not associated with maternal toxicity (see Animal Data ). In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% - 4% and 15% - 20%, respectively.
What are the important warnings for Tizanidine?▼
5 WARNINGS AND PRECAUTIONS Hypotension: monitor for signs and symptoms of hypotension, in particular in patients receiving concurrent antihypertensives; tizanidine should not be used with other α 2 -adrenergic agonists ( 5.1 , 7.7 ) Risk of liver injury: monitor ALTs; discontinue tizanidine if liver injury occurs ( 5.2 ) Sedation: tizanidine may interfere with everyday activities; sedative effects of tizanidine, alcohol, and other central nervous system (CNS) depressants are additive ( 5.3 , 7.4 ) Hallucinations: consider discontinuation of tizanidine ( 5.4 ) 5.1 Hypotension Tizanidine is an α2-adrenergic agonist that can produce hypotension [see Adverse Reactions ( 6.1 ) and Drug Interactions ( 7.5 )] . 4 CONTRAINDICATIONS Concomitant use with strong CYP1A2 inhibitors ( 4 , 7.1 ) Patients with a history of hypersensitivity to tizanidine or the ingredients in Tizanidine ( 4 , 5.5 ) Tizanidine is contraindicated in patients: taking strong CYP1A2 inhibitors [see Drug Interactions ( 7.1 )]. with a history of hypersensitivity to tizanidine or the ingredients in Tizanidine.
Related Medications
Arnica Montana 1x Hpus
arnica montana 1x hpus
Reduces pain, swelling, anddiscolorationfrom bruises
Arnica Montana, Belladonna, Cina, Coccus Cacti, Corallium Rubrum, Cuprum Metallicum, Drosera, Ferrum Phosphoricum, Ipecacuanha, Solidago Virgaurea
arnica montana, belladonna, cina, coccus cacti, corallium rubrum, cuprum metallicum, drosera, ferrum phosphoricum, ipecacuanha, solidago virgaurea
Copper-containing Intrauterine Device [EPC]
Uses Assists with the temporary relief of cough.
Bartonella Clarridgeiae, Bartonella Elizabethae, Bartonella Henselae, Bartonella Quintana, Bartonella Vinsonii, Bartonella Washoensis, Bartonella Bacilliformis Dna, Bartonella Clarridgeiae Dna, Bartonella Elizabethae Dna, Bartonella Henselae Dna, Bartonella Quintana Dna, Bartonella Vinsonii Dna, Bartonella Washoensis Dna
bartonella clarridgeiae, bartonella elizabethae, bartonella henselae, bartonella quintana, bartonella vinsonii, bartonella washoensis, bartonella bacilliformis dna, bartonella clarridgeiae dna, bartonella elizabethae dna, bartonella henselae dna, bartonella quintana dna, bartonella vinsonii dna, bartonella washoensis dna
Dosage form: LIQUID. Active ingredients: BARTONELLA BACILLIFORMIS DNA (1 [hp_M]/mL); BARTONELLA CLARRIDGEIAE (1 [hp_M]/mL); BARTONELLA CLARRIDGEIAE DNA (1 [hp_M]/mL); BARTONELLA ELIZABETHAE (1 [hp_M]/mL); BARTONELLA HENSELAE (1 [hp_M]/mL); BARTONELLA HENSELAE DNA (1 [hp_M]/mL); BARTONELLA QUINTANA (1 [hp_M]/mL); BARTONELLA QUINTANA DNA (1 [hp_M]/mL); BARTONELLA VINSONII (1 [hp_M]/mL); BARTONELLA VINSONII DNA (1 [hp_M]/mL); BARTONELLA WASHOENSIS (1 [hp_M]/mL); BARTONELLA WASHOENSIS DNA (1 [hp_M]/
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.